ANG Lifesciences to acquire 51% stake in Baddi Agro

09 Nov 2021 Evaluate

ANG Lifesciences India's board is all set to invest in the Equity Shares and Redeemable Cumulative Preference Shares of Baddi Agro. Consequent to the acquisition of 51% Equity stake by the company, Baddi Agro will become the subsidiary company of ANG Lifesciences India. The object of the said acquisition is to expand its business activities for manufacturing of Menthol API Derivative and other related products. The company's Board of Directors in their meeting held on November 8, 2021 had decided the same.

ANG Lifesciences India, incorporated in the year 2006, started with the business of manufacturing and marketing of finished pharmaceutical formulation in a dosage form of Sterile Dry Powder Injection Vial.

ANG Lifesciences Share Price

53.16 0.06 (0.11%)
27-May-2024 11:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1477.00
Dr. Reddys Lab 5824.25
Cipla 1481.60
Zydus Lifesciences 1064.95
Lupin 1631.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.